Simplifeye Expands Technology Suite With Invite Platform

Article

The Invite platform streamlines patient scheduling and reactiviation.

Technology solutions company Simplifeye has expanded its technology suite or healthcare practices. The company’s new Invite technology is an artificial technology (AI) powered tool that is designed to create customized and automated outreach to fill practices’ schedules with ideal patients with open treatment plans.

Simplifeye Invite offers ample appointments resulting from its ability to match patients with incomplete treatments to openings in a practice schedule, filling unexpected gaps due to cancellations. It also can segment by procedure, insurance coverage, last treatment date, and more options to help identify priority patients.

Text-to-schedule and email appointment invites right to patients, providing a direct link for patients to schedule then and there. It’s designed to increase conversion of planned treatments to scheduled appointments and simplify scheduling and reactivation of patients combined with increased case acceptance and revenue.

Recent Videos
GNYDM24 Product Focus: Josh Gosnell, Vice President, Business Development at Adit, explains how cloud-based analytics and patient communication software can enable practices to run more efficiently.
GNYDM24 Product Focus: Michele Gabriel of DDSmatch stops by the DPR booth at the Javits Center in New York.
GNYDM24 Product Focus: Debra Engelhardt-Nash talks about how Weave's systems can help with increasing patient acceptance and with practices getting paid.
The Uptime Health Story: An Interview with Uptime Health CEO and Co-Founder Jinesh Patel
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
GNYDM23 Product Focus: Henry Schein Maxima Turbo Class B Sterilizer with Dyan Jayjack
GNYDM23 Product Focus: Henry Schein Maxima PowerClean 210 with Dyan Jayjack
Related Content
© 2025 MJH Life Sciences

All rights reserved.